{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:51:14Z","timestamp":1758707474664,"version":"3.40.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010037","name":"Chongqing Youth Science and Technology Talent Training Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015295","name":"Chongqing Social Science Planning Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.retram.2024.103472","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T07:35:35Z","timestamp":1727249735000},"page":"103472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation"],"prefix":"10.1016","volume":"73","author":[{"given":"Meilin","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.retram.2024.103472_bib0001","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJM199403243301206","article-title":"Bone marrow transplantation","volume":"330","author":"Armitage","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.retram.2024.103472_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101139","article-title":"Optimal management of chemotherapy-induced thrombocytopenia with thrombopoietin receptor agonists","volume":"63","author":"Al-Samkari","year":"2024","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12959-023-00509-z","article-title":"Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis","volume":"21","author":"Dong","year":"2023","journal-title":"Thromb J"},{"issue":"11","key":"10.1016\/j.retram.2024.103472_bib0004","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/17474086.2021.2009337","article-title":"Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review","volume":"14","author":"Yao","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.retram.2024.103472_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1260487","article-title":"Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently","volume":"10","author":"Yassin","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.retram.2024.103472_bib0006","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2024.103472_bib0007","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2017-01-761262","article-title":"A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy","volume":"130","author":"Kong","year":"2017","journal-title":"Blood."},{"issue":"10","key":"10.1016\/j.retram.2024.103472_bib0008","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood-2014-06-581868","article-title":"A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP","volume":"125","author":"Zhou","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.retram.2024.103472_bib0009","article-title":"Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2024.103472_bib0010","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fphar.2020.00940","article-title":"Efficacy and safety of recombinant human thrombopoietin on sepsis patients with thrombocytopenia: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.retram.2024.103472_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.02.023","article-title":"Recombinant human thrombopoietin promotes platelet engraftment in severe aplastic anemia patients following treatment with haploid hematopoietic stem cell transplantation using modified post-transplantation cyclophosphamide","author":"Fu","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.retram.2024.103472_bib0012","first-page":"207","article-title":"Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation","volume":"39","author":"Song","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0013","first-page":"241","article-title":"Effect of recombinant human thrombopoietin (rhTPO) on hematopoietic reconstitution in allogeneic hematopoietic stem cell transplantation model","volume":"31","author":"Qiu","year":"2023","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.retram.2024.103472_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211068037","article-title":"Efficacy of recombinant human thrombopoietin for the treatment of secondary failure of platelet recovery after allogeneic HCT","volume":"28","author":"Cao","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03256939","article-title":"Safety of recombinant human thrombopoietin in adults after related donor haploidentical hematopoietic stem cell transplantation: a pilot study","volume":"31","author":"Liu","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"7","key":"10.1016\/j.retram.2024.103472_bib0016","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41409-022-01689-4","article-title":"Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant","volume":"57","author":"Sola","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1083-8791(00)70049-8","article-title":"A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation[J]","volume":"6","author":"Nash","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.transci.2018.04.014","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"16","key":"10.1016\/j.retram.2024.103472_bib0019","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2020002257","article-title":"Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation","volume":"4","author":"Tang","year":"2020","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.retram.2024.103472_bib0020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2010.218","article-title":"Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival","volume":"46","author":"Ram\u00edrez","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.retram.2024.103472_bib0021","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2016.06.003","article-title":"Risk factors and impact of secondary failure of platelet recovery after allogeneic stem cell transplantation","volume":"22","author":"Akahoshi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0022","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.retram.2024.103472_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1043836","article-title":"Donor-specific anti-human leukocyte antigen antibodies predict prolonged isolated thrombocytopenia and inferior outcomes of haploidentical hematopoietic stem cell transplantation","volume":"2017","author":"Zhao","year":"2017","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2009.10.004","article-title":"Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation","volume":"38","author":"Pr\u00e9bet","year":"2010","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.2001.02468.x","article-title":"Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose","volume":"112","author":"Dominietto","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0026","first-page":"4","article-title":"Risk factors of secondary hematopoietic cell reduction after allogeneic hematopoietic stem cell transplantation","volume":"35","author":"Zhi-Juan","year":"2014","journal-title":"Chin J Hematol"},{"issue":"5","key":"10.1016\/j.retram.2024.103472_bib0027","first-page":"383","article-title":"New progress of thrombocytopenia during hematopoietic stem cell transplantation in patients with hematological malignancies","author":"Fujia","year":"2020","journal-title":"Int J Blood Transf Hematol"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0028","first-page":"11","article-title":"The major autopsy findings in adult patients after hematopoietic stem cell transplantation","volume":"12","author":"Khayyata","year":"2007","journal-title":"Ann Transplant"},{"issue":"6481","key":"10.1016\/j.retram.2024.103472_bib0029","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/369568a0","article-title":"Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin","volume":"369","author":"Kaushansky","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.retram.2024.103472_bib0031","first-page":"626","article-title":"Research progress of platelet-producing drugs","volume":"45","author":"Zhi-Yuan","year":"2019","journal-title":"J Milit Med"},{"issue":"10","key":"10.1016\/j.retram.2024.103472_bib0032","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.retram.2024.103472_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107982","article-title":"Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin","volume":"99","author":"Yuan","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0034","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00277-014-2158-1","article-title":"Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial","volume":"94","author":"Han","year":"2015","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.retram.2024.103472_bib0035","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.bbmt.2017.06.010","article-title":"Recombinant human thrombopoietin promotes platelet engraftment and improves prognosis of patients with myelodysplastic syndromes and aplastic anemia after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Wang","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.retram.2024.103472_bib0036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.retram.2024.103472_bib0037","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/asheducation-2017.1.645","article-title":"HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities","volume":"2017","author":"Gladstone","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-016-2156-2","article-title":"New agents in HSC mobilization","volume":"105","author":"Domingues","year":"2017","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.retram.2024.103472_bib0039","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2141.1997.2283045.x","article-title":"Thrombopoietin alone stimulates the early proliferation and survival of human erythroid, myeloid and multipotential progenitors in serum-free culture","volume":"98","author":"Yoshida","year":"1997","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.retram.2024.103472_bib0040","first-page":"401","article-title":"Chinese Guidelines for the treatment of severe sepsis\/septic shock (2014)","year":"2015","journal-title":"Chin J Crit Care Emerg Med"},{"issue":"8","key":"10.1016\/j.retram.2024.103472_bib0041","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00134-013-2963-3","article-title":"Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study","volume":"39","author":"Thiolliere","year":"2013","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.retram.2024.103472_bib0042","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704724","article-title":"Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial","volume":"34","author":"Schmitz","year":"2004","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:51:48Z","timestamp":1744876308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318624000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2452318624000345"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2024.103472","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect and safety of recombinant human thrombopoietin on haematopoietic reconstitution after allogeneic haematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2024.103472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103472"}}